GSK3B and Wilson disease: In the WD group, Western blotting and quantitative analysis revealed significant decreases in cortical p-GSK-3β and p-Akt levels compared with the Control group, but no changes in total protein levels (Figures 6A,B), suggesting GSK-3β activation and Akt inhibition after WD-TBI.